Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Pain 3Vomiting 1Stomatitis 1Squamous Cell Carcinoma of Head and Neck 1Sleep Wake Disorders 1Opioid-Related Disorders 1Neoplasms 1Nausea 1Lymphoma, Follicular 1Cancer Pain 1Breakthrough Pain 1

Interventions

N-((1-((5-(4-fluorophenyl)-2-methyl-4-thiazolyl)carbonyl)-2-piperidinyl)methyl)-4-benzofurancarboxamide 1Methadone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Sleep Wake Disorders × Methadone × Clear all
NCT00930332 2024-02-12

Methadone Hydrochloride as First-Line Therapy in Treating Patients With Chronic Neuropathic Cancer Pain

Canadian Cancer Trials Group

Phase 1 Terminated
8 enrolled

Nausea, Pain, Sleep Wake Disorders, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡